UNSPSC 41142025: Mucopolysaccharides (nonquantitative) test system

In this classification, Mucopolysaccharides (nonquantitative) test system connotes a device used to measure Mucopolysaccharides (nonquantitative) levels. US FDA regulates Mucopolysaccharides (nonquantitative) test system under 21 CFR 862.1505 and under FDA product code JQN.

UNSPSC 41142025 Mucopolysaccharides (nonquantitative) test system is a Commodity code that encompasses laboratory diagnostic kits and reference materials used by forensic, public health, and medical testing laboratories for substance analysis, drug screening, and DNA evaluation. State and local governments procure under this code Direct ELISA testing kits for immunoanalysis of controlled substances and other drugs, certified reference materials and drug standards for analytical method validation and forensic sample analysis, DNA screening kits for qualitative and multiplex PCR applications, and associated laboratory reagents and markers. The issuing bodies span state law enforcement agencies (Texas Department of Public Safety, Texas Department of Criminal Justice, Texas Health and Human Services Commission on behalf of the Department of State Health Services), state environmental and health regulators (Illinois Department of Financial and Professional Regulation), and county forensic laboratories (Pinellas County, Florida). The code shows sporadic activity rather than a steady stream of opportunities.

Recent solicitations concentrate in Texas and Florida. The Texas Department of Public Safety posted an IFB on July 9, 2026, for immunalysis reagent kits—Direct ELISA testing kits for cannabinoids, opiates, PCP, amphetamines, and other controlled substances—with bids due July 23, 2026. Pinellas County, Florida, in partnership with the Florida Department of Law Enforcement, issued an Invitation to Quote on April 23, 2026, for certified reference materials (drug standards) with specific concentrations and ISO/IEC 17025 accreditation compliance for use in forensic toxicology and seized drug analysis, with approximately $49,034.00 of $72,126.85 in federal Coverdell Act funds allocated to equipment and supplies procurement. The Texas Health and Human Services Commission posted a competitive IFB on February 10, 2026, for QIAxcel and QIAamp DNA screening kits for the Department of State Health Services state laboratory, with a historical spend range of $25,050.00 to $30,000.00 for fiscal year 2025. Pinellas County offers a five percent price preference for Certified Small Business Enterprises, and Texas procurements typically require HUB Subcontracting Plans or equivalent historically underutilized business participation.